Silky Chotai

Cleveland Clinic Lerner College of Medicine — United States

Medicine · Health Sciences

33h-index3.9kcitations248works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Spine and Intervertebral Disc Pathology(110), Meningioma and schwannoma management(49), Spinal Fractures and Fixation Techniques(45), Musculoskeletal pain and rehabilitation(35), Cervical and Thoracic Myelopathy(31)

Publications244 total

Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology
Journal of Neurological Surgery Part B Skull Base·2026
Tuberculum Sellae Meningiomas: Anatomical Determinants of Surgical Approach
Journal of Neurological Surgery Part B Skull Base·2026
Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology
Neuro-Oncology·2025Open Access
BIOM-08. CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA
Neuro-Oncology·2025Open Access
Tert expression in meningiomas predicts progression-free survival independent of tert promoter mutation
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)·2025
BIOM-113. TERT EXPRESSION IN MENINGIOMAS PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENT OF TERT PROMOTER MUTATION
Neuro-Oncology·2025Open Access
Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study
The Lancet Oncology·2025· 4 cited
53 DEVELOPMENT AND VALIDATION OF A MOLECULAR CLASSIFIER OF MENINGIOMAS
Neuro-Oncology Advances·2025· 1 citedOpen Access
33 TERT EXPRESSION PREDICTS PROGRESSION-FREE SURVIVAL IN MENINGIOMAS
Neuro-Oncology Advances·2025Open Access
17 CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA
Neuro-Oncology Advances·2025Open Access
17 CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA
Neuro-Oncology Advances·2025Open Access
Abstract 4592: TERT expression predicts progression-free survival in meningiomas
Cancer Research·2025
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
JAMA Oncology·2025· 10 citedOpen Access
2091 Molecular Classification Refines Surgical and Radiotherapeutic Decision Making in Meningioma and Prospective Validation
Neurosurgery·2025· 1 cited
Development and validation of a molecular classifier of meningiomas
Neuro-Oncology·2024· 13 citedOpen Access
Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
Neuro-Oncology·2024· 6 citedOpen Access
Variations in the management of pediatric cerebral vasospasm
Journal of Neurosurgery Pediatrics·2024· 1 cited
IMMU-70. GLIOBLASTOMA DERIVED IL-8 INSTRUCTS IMMUNE CELL IDENTITY IN LATERAL VENTRICLE CONTACTING TUMORS
Neuro-Oncology·2024Open Access
PDOC-02 SUB-SAHARAN AFRICAN EXPERIENCE OF NEUROSURGICAL-ONCOLOGIC CARE: CHALLENGES AND BARRIERS ENCOUNTERED AT 7 CANCER TREATMENT CENTERS
Neuro-Oncology Advances·2024Open Access
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Nature Medicine·2024· 52 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Clinton J. Devin(29), Matthew J. McGirt(24), Paul Park(15), Anthony L. Asher(15), Ahilan Sivaganesan(13), Kristin R. Archer(11), Kevin T. Foley(11), Mohamad Bydon(10), Christopher I. Shaffrey(8), Praveen V. Mummaneni(8), John J. Knightly(8), Steven D. Glassman(7), Joseph B. Wick(7), Hui Nian(6), Frank E. Harrell(6), Erica F. Bisson(6), John A. Sielatycki(6), Panagiotis Kerezoudis(5), Mark E. Shaffrey(5), Songtao Qi(5)